The Regulation of Biological Product Marketing: An Introduction
Learn the legal and regulatory requirements surrounding communications about biologics and biosimilars. Define misbranding, label and labeling, and off-label promotion. Identify the basic rules for advertising and promotion.
Nathan A. Beaton, Associate, Latham & Watkins LLP
Kathryn Culver, Associate, Latham & Watkins LLP
This session was recorded as part of FDLI’s Introduction to Biological Products, Including Vaccines, Biosimilars, Cell and Gene Therapies, and Other Advanced Therapies Course in October 2022.